Mass cytometry and artificial intelligence define CD169 as a specific marker of SARS-CoV2-induced acute respiratory distress syndrome
M. Roussel, J. Ferrant, F. Reizine, S. Le Gallou, J. Dulong, S. Carl, M. Lesouhaitier, M. Gregoire, N. Bescher, C. Verdy, M. Latour, I. Bezier, M. Cornic, S. Leonard, J. Feuillard, , K. Tarte
The paper identifies a specific immune signature in COVID-19-associated ARDS using mass cytometry and AI, showing it differs from other ARDS causes and is linked to adverse ICU outcomes.
bioRxiv · Sep 22, 2020Immunology